Abiopharma

EDAP to Announce Second Quarter 2025 Financial Results on August 28, 2025

Insmed Reports Second-Quarter 2025 Financial Results and Provides Business Update

Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

BioLineRx to Report Second Quarter 2025 Results on August 14, 2025

Kiora Pharmaceuticals to Showcase Its Retinal Disease Therapeutic Pipeline at The H.C. Wainwright 5th Annual Ophthalmology Virtual Conference

LENSAR Reports Second Quarter 2025 Results and Provides Business Update

New Form 6-K - Haleon plc Filed: 2025-08-07 AccNo: 0001654954-25-009157 Size: 39 KB

New Form 10-Q - IMMUNIC, INC. Filed: 2025-08-07 AccNo: 0001280776-25-000012 Size: 12 MB

New Form 8-K - Warby Parker Inc. Filed: 2025-08-07 AccNo: 0001504776-25-000024 Size: 456 KB Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

Warby Parker - Warby Parker Announces Second Quarter 2025 Results

Lilly reports second-quarter 2025 financial results and raises guidance

Warby Parker Announces Second Quarter 2025 Results

New Form 10-Q - Nuvalent, Inc. Filed: 2025-08-07 AccNo: 0000950170-25-104532 Size: 8 MB

New Form 8-K - IMMUNIC, INC. Filed: 2025-08-07 AccNo: 0001193805-25-001164 Size: 16 MB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - BECTON DICKINSON & CO Filed: 2025-08-07 AccNo: 0000010795-25-000069 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits